Skip to main content
CIZZLE BIOTECHNOLOGY HOLDINGS PLC logo

CIZZLE BIOTECHNOLOGY HOLDINGS PLC — Investor Relations & Filings

Ticker · CIZ ISIN · GB00BNG2VN02 LEI · 213800G3OS3SA2J1Y358 IL Professional, scientific and technical activities
Open in API
Filings indexed 305 across all filing types
Latest filing 2024-07-09 Remuneration Information
Country GB United Kingdom
Listing IL CIZ

About CIZZLE BIOTECHNOLOGY HOLDINGS PLC

https://cizzlebiotechnology.com/

Cizzle Biotechnology Holdings PLC is a cancer diagnostics developer focused on the early detection of lung cancer. The company is advancing a non-invasive, cost-effective blood test designed to identify lung cancer at its earliest stages, often before symptoms appear. The test utilizes a proprietary CIZ1B biomarker and an advanced immunoassay. Its primary goal is to improve patient outcomes by enabling swift, curative medical intervention. The technology aims to streamline the diagnostic pathway, reduce reliance on CT scans which can have high false-positive rates, and eliminate unnecessary invasive follow-up procedures. The company, a spin-out from the University of York, is conducting clinical trials to support global regulatory approval and adoption of its technology.

Recent filings

Filing Released Lang Actions
Issue of Share Options in Lieu of Consultancy Fees
Remuneration Information Classification · 1% confidence The document begins with an 'RNS Number' and is dated '09 July 2024'. The content describes the 'Issue of Share Options in Lieu of Consultancy Fees' to a consultant (Makabo Limited). This involves the granting of share options, which directly impacts the company's capital structure and is a form of compensation/financing activity. Since the document details a specific transaction involving the issuance of options (a form of share capital change or financing), it fits best under Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). However, the core announcement is about issuing options as payment, which is a specific capital structure event. Given the options granted are outside existing schemes and the details of the grant price and vesting are provided, 'SHA' (Share Issue/Capital Change) is highly relevant, as is 'CAP' (Capital/Financing Update). Since it is a direct announcement of a share-based transaction, SHA is slightly more precise than the broader CAP. The presence of the RNS header suggests it is a regulatory announcement, but the specific content points to SHA/CAP. I will classify it as SHA as it details the grant of new options, affecting the share count/structure, and it is clearly not a general regulatory filing (RNS) or a report announcement (RPA).
2024-07-09 English
Result of AGM
AGM Information Classification · 1% confidence The document is an official announcement filed via RNS (RNS Number: 6238T) dated June 24, 2024. The title explicitly states 'Result of AGM' and the content details that 'all resolutions were voted on by a show of hands and were passed,' followed by a table showing the proxy votes for each resolution, including the approval of the annual report and the re-appointment of directors. This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions the AGM, the focus is on the *results* of the voting, not the presentation materials (AGM-R) or the proxy solicitation materials (PSI).
2024-06-24 English
Update on North American Strategic Licensing MoU
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5808S' and contains standard regulatory announcement formatting, including contact information for financial advisors and the closing statement referencing RNS, the news service of the London Stock Exchange, which is approved by the FCA. The content announces an 'Update on Strategic Licensing and Partnership Memorandum of Understanding' and an 'Extension of Research Agreement.' This is a corporate announcement regarding business development, licensing, and research milestones, rather than a full financial report (like 10-K or IR) or a specific regulatory filing like a Director's Dealing or Proxy Statement. Since it is a general regulatory announcement distributed via RNS that doesn't fit the more specific categories (like CAP, MANG, or DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2024-06-17 English
Cizzle Biotechnology Holdings plc - Final results for the year ended 31 December 2023
Annual Report Classification · 1% confidence The document is explicitly titled 'Annual Report for the year ended 31 December 2023'. It contains comprehensive sections including company information, Chair's statement, board of directors profiles, strategic report, and financial overview. It covers the full fiscal year and provides substantive financial data and management analysis, fitting the definition of an Annual Report (10-K). FY 2023
2024-06-11 English
Notice of Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states 'Notice of Annual General Meeting' and provides the date, time, and location for the AGM. This directly relates to the Annual General Meeting (AGM) process. Although it is a notice, the content is specific to the AGM event itself, making 'AGM-R' (AGM Information) the most appropriate classification, as it serves as the official announcement/notice material for the meeting. It is not a general regulatory filing (RNS) because it is highly specific to the AGM.
2024-06-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to 'acquisition or disposal of voting rights', 'shareholder(s)', and 'Total positions of person(s) subject to the notification obligation' crossing a threshold (10.01%). This structure is characteristic of regulatory filings concerning significant changes in share ownership. The presence of 'RNS Number' and reference to the 'FCA' (Financial Conduct Authority) confirms it is a regulatory disclosure. This specific type of filing, reporting changes in major shareholdings, maps directly to the definition of Major Shareholding Notification (MRQ).
2024-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.